Ser509

Site Information
GHRKRAssENERLQy SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 36126619

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	lung cancer ( 3 ) , non-small cell lung adenocarcinoma ( 3 ) , pancreatic ductal adenocarcinoma ( 2 )
Relevant cell line - cell type - tissue:	'pancreatic, ductal'-pancreas ( 2 ) , HeLa (cervical) ( 1 ) , lung ( 3 )

References
1	Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94 25159151 Curated Info
2	Britton D, et al. (2014) Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One 9, e90948 24670416 Curated Info
3	Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96 23911959 Curated Info